Skip to content
ClinCalc Pro
Menu
Vaccine

Meningococcal group B vaccine

Brand names: Bexsero, Trumenba

The meningococcal group B vaccine is a multicomponent protein-based vaccine providing active immunisation against invasive disease caused by Neisseria meningitidis serogroup B, given as part of the UK routine infant programme.

Dosing — national schedule

Vaccines and immunoglobulins are given by national schedule or product-specific guidance: see the UK Green Book (UKHSA) and the product's SmPC.

Clinical monograph

How it works

It contains recombinant meningococcal B surface proteins together with outer membrane vesicle antigens that elicit bactericidal antibodies against serogroup B strains expressing the relevant antigens.

Prescribing in practice

  • Fever is common after infant doses, and prophylactic paracetamol is recommended around vaccination to reduce its incidence and severity per UK guidance.
  • It is given as part of the routine infant schedule, and the recommended dosing course should be completed for optimal protection.
  • It targets serogroup B and does not replace meningococcal ACWY or other meningococcal immunisation where indicated.

Monitoring

Observe for immediate hypersensitivity after administration and monitor for post-vaccination fever in infants.

Counselling the patient

  • Fever is common after this vaccine in babies, and paracetamol is advised around the time of vaccination.
  • Complete all the recommended doses for the best protection.
  • Some redness or tenderness at the injection site is normal and settles.

Evidence & guidelines

UK guidance from the national immunisation programme recommends routine infant meningococcal B vaccination with prophylactic paracetamol to mitigate fever.

Reference: UK Green Book; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.